Antiphospholipid antibody syndrome as a cause of inferior vena cava thrombosis.
Tütüncüler
Filiz
F
Cihangiroğlu
M Mutlu
MM
Aydinoğlu
A Hakan
AH
Aygün
A Denizmen
AD
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000188:drug therapy; D002648:Child; D005500:Follow-Up Studies; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D008297:Male; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome; D014682:Vena Cava, Inferior / Q000473:pathology*; D014859:Warfarin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D007136:Immunoglobulins; D014859:Warfarin; D000667:Ampicillin; D006493:Heparin